Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Congenital Abnormality
|
73 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Congenital defects
|
6 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1 | 2010 | 2010 | |||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Hypertensive disease
|
1085 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1 | 2017 | 2017 | |||||||
Irritable Bowel Syndrome
|
52 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Malignant neoplasm of prostate
|
1082 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Metabolic Diseases
|
50 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Myocardial Ischemia
|
103 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Neural Tube Defects
|
122 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Osteoporosis
|
182 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Primary lactose intolerance
|
1 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Prostate carcinoma
|
1168 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Renal Cell Carcinoma
|
288 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.010 | 1 | 2010 | 2010 | |||||||
Obesity
|
1111 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.040 | 1.000 | 4 | 2011 | 2017 | ||||||
Blood Protein Measurement
|
2575 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.700 | 1.000 | 2 | 2018 | 2018 | ||||||
Body mass index
|
2689 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.700 | 1.000 | 2 | 2015 | 2018 | ||||||
Hip circumference
|
116 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||
LACTASE PERSISTENCE
|
9 | 0.752 | 0.400 | 2 | 135851076 | intron variant | G/A;C | snv | 0.800 | 0.941 | 17 | 2009 | 2019 |